Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Overall, our results indicate that the BMP9/ALK1 hub critically mediates vascular quiescence by limiting PI3K signaling and suggest that PI3K inhibitors could be used as novel therapeutic agents to treat hereditary hemorrhagic telangiectasia. 29449337 2018
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. 28796572 2017
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Finally, tacrolimus stimulated Smad1/5/8 signaling in C2C12 cells expressing BMP9-unresponsive ALK1 HHT mutants and in HHT patient blood outgrowth ECs. 28973643 2017
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions. 26645978 2016
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Although mutations in ALK1, a member of the transforming growth factor (TGF)-β/bone morphogenetic protein (BMP) receptor family, have been linked to hereditary hemorrhagic telangiectasia, a human vascular disease, the roles of activin receptor-like kinase 1 (ALK-1) signals in LV formation largely remain to be elucidated. 24133138 2013
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Among them, the identification of bone morphogenetic protein receptor type 2 (BMPR2) as the major predisposing gene and activin A receptor type II-like kinase-1 (ACVRL1, also known as ALK1) as the major gene when PAH is associated with hereditary hemorrhagic telangiectasia. 24355637 2013
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations. 23124896 2013
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Familial cases have long been recognised and are usually due to mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2), or, much less commonly, two other members of the transforming growth factor-β superfamily, activin-like kinase-type 1 (ALK1), and endoglin (ENG), which are associated with hereditary hemorrhagic telangiectasia. 23733703 2011
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. 19357124 2009
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Patients with hereditary hemorrhagic telangiectasia genotype ALK-1 (HHT2-ALK-1) with nonsense mutation demonstrated tendentially higher health-related quality of life (HR-QOL) scores than patients with HHT with genotype ENG (HHT1-ENG) with missense mutation. 18855162 2009
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Familial cases have long been recognized and are usually due to mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2), or, much less commonly, 2 other members of the transforming growth factor-beta superfamily, activin-like kinase-type 1 (ALK1) and endoglin (ENG), which are associated with hereditary hemorrhagic telangiectasia. 19555857 2009
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE To our knowledge, this is the first report on whole ALK1 gene deletions in HHT patients. 18312453 2008
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. 17388964 2007
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Endoglin and ALK1 mutations are thought to affect endothelial cell metabolism, angiogenesis and vascular remodelling, even if the precise mechanism leading to the HHT lesions is still obscure. 18220803 2007
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations. 16542389 2006
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Functional analysis of mutations in the kinase domain of the TGF-beta receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia. 16282348 2006
Hereditary hemorrhagic telangiectasia
0.100 AlteredExpression disease BEFREE These findings indicate that the mutation causes truncation of the ALK-1 protein at the post-transcriptional level; the plasma thrombomodulin may provide an easy diagnostic indicator in HHT patients. 16861286 2006
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Defective TGF-beta signaling in endothelial cells attributable to mutations in endoglin or the type I receptor ALK-1 leads to hereditary hemorrhagic telangiectasia, whereas defective BMP signaling attributable to mutations in the BMP receptor II has been associated with development of primary pulmonary hypertension. 16675726 2006
Hereditary hemorrhagic telangiectasia
0.100 AlteredExpression disease BEFREE Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1. 16470589 2006
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Mutations in the gene that codes for activin receptor-like kinase (ALK 1), another transforming growth factor beta (TGF-beta) cell surface receptor, appear responsible for the rare occurrence of pulmonary arterial hypertension in patients with hereditary hemorrhagic telangiectasia. 16121312 2005
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations. 15712270 2005
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Exonic mutations in BMPR2 are found in about 50% of patients with familial PAH, and ALK1 mutations are found in a minority of patients with hereditary hemorrhagic telangiectasia and co-existent PAH. 15194176 2004
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Mutations in the endoglin (ENG) or ALK1 genes are responsible for hereditary hemorrhagic telangiectasia types 1 and 2 (HHT1 and HHT2), respectively, a dominant vascular dysplasia caused by haploinsufficiency. 15375013 2004
Hereditary hemorrhagic telangiectasia
0.100 GeneticVariation disease BEFREE Clinical phenotypes, ALK1 gene mutation and level of related plasma proteins in Chinese hereditary hemorrhagic telangiectasia. 15198877 2004
Hereditary hemorrhagic telangiectasia
0.100 Biomarker disease BEFREE Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. 15024723 2004